Polymyxin B
Top View
- Self-Assembling Dipeptide Antibacterial Nanostructures with Membrane Disrupting Activity
- European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) Sales Data and Animal Population Data Reporting Protocol (Version 4)
- Swedres-Svarm 2016
- Polymyxin B B
- Recent Advances in Design of Antimicrobial Peptides and Polypeptides Toward Clinical Translation
- A Review of the Clinical Pharmacokinetics of Polymyxin B
- Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
- Colistin and Polymyxin B: a Re-Emergence
- Sales of Veterinary Antimicrobial Agents in 31 European Countries in 2018
- Burden and Current Global Management on GNB Infections: Lessons from the Global-PPS of Antimicrobial Consumption and Resistance in 335 Hospitals Worldwide
- Estonian Statistics on Medicines 2014
- Antimicrobial Lipopeptide Tridecaptin A1 Selectively Binds to Gram-Negative Lipid II
- WHO Regional Office for Europe Antimicrobial Medicines Consumption (AMC) Network: AMC Data, 2014-2018
- Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
- Polymyxin B for Injection, USP
- Polymyxin B for Injection, USP500,000 Units/Vial
- Cefepime Combined with Amoxicillin/Clavulanic Acid: a New Choice For
- Antimicrobial Prescribing Guidelines for Sheep